Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism
出版年份 2020 全文链接
标题
Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism
作者
关键词
-
出版物
BMC CANCER
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-02
DOI
10.1186/s12885-020-07062-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy
- (2019) Erlend Skaga et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Bcl‐2/Bcl‐xL inhibition predominantly synergistically enhances the anti‐neoplastic activity of a low‐dose CUSP9 repurposed drug regime against glioblastoma
- (2019) Marc‐Eric Halatsch et al. BRITISH JOURNAL OF PHARMACOLOGY
- HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of Iran
- (2019) Arash Memarnejadian et al. INTERVIROLOGY
- Reversal of the Warburg effect with DCA in PDGF‑treated human PASMC is potentiated by pyruvate dehydrogenase kinase‑1 inhibition mediated through blocking Akt/GSK‑3β signalling
- (2018) Bingbing Li et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Inositol-C2-PAF acts as a biological response modifier and antagonizes cancer-relevant processes in mammary carcinoma cells
- (2018) Carsten Pelz et al. CELLULAR ONCOLOGY
- Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
- (2017) Xiaofeng Dai et al. Journal of Cancer
- Results from a phase I, dose-escalation study of PX-478, an orally available inhibitor of HIF-1α.
- (2017) R. Tibes et al. JOURNAL OF CLINICAL ONCOLOGY
- Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation
- (2016) Rebecca H. Chisholm et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction
- (2016) Agostinho Lemos et al. MEDICINAL RESEARCH REVIEWS
- Optimization of drug combinations using Feedback System Control
- (2016) Patrycja Nowak-Sliwinska et al. Nature Protocols
- Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer
- (2015) Andrea Weiss et al. ANGIOGENESIS
- Large-scale exploration and analysis of drug combinations
- (2015) Peng Li et al. BIOINFORMATICS
- The Anatomy of Medical Research
- (2015) Hamilton Moses et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
- (2015) Richard E. Kast et al. Oncotarget
- A streamlined search technology for identification of synergistic drug combinations
- (2015) Andrea Weiss et al. Scientific Reports
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways
- (2014) S J Allison et al. Oncogenesis
- Primary and secondary distant metastatic breast cancer: Two sides of the same coin
- (2013) Uwe Güth et al. BREAST
- Dual Targeting of the Warburg Effect with a Glucose-Conjugated Lactate Dehydrogenase Inhibitor
- (2013) Emilia C. Calvaresi et al. CHEMBIOCHEM
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
- (2011) Oscar Vadas et al. Science Signaling
- Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination
- (2010) Hanna Berglind et al. CANCER BIOLOGY & THERAPY
- Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1α
- (2009) Yoon-Mi Lee et al. CARCINOGENESIS
- 6-Shogaol, an Active Constituent of Dietary Ginger, Induces Autophagy by Inhibiting the AKT/mTOR Pathway in Human Non-Small Cell Lung Cancer A549 Cells
- (2009) Jen-Yu Hung et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Preclinicalversusclinical drug combination studies
- (2008) Ting-Chao Chou LEUKEMIA & LYMPHOMA
- Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1
- (2008) M. Y. Koh et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now